Madrigal Pharmaceuticals (MDGL) Share-based Compensation (2010 - 2026)
Madrigal Pharmaceuticals' Share-based Compensation was $35.37 million in Q2 2026, up 40.6% from $25.16 million a year earlier and up 4.0% from the prior quarter.
Powered by 
Analysis
Madrigal Pharmaceuticals (MDGL) Share-based Compensation (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Madrigal Pharmaceuticals' Share-based Compensation was $121.43 million through Jun 30, 2026, up 48.7% year-over-year; for FY2025, it came in at $98.13 million, up 22.8% from FY2024.
- Share-based Compensation has now increased for five consecutive years, with a five-year compound annual growth rate of 36.5% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $79.88 million in FY2024 (+60.6%), $49.74 million in FY2023 (+57.3%), $31.63 million in FY2022 (+17.7%) and $26.87 million in FY2021 (+29.6%).
- The Q2 2026 figure marks the highest quarterly Share-based Compensation in data going back to Q3 2010.
- Compared with a year earlier, Share-based Compensation has increased for 16 straight quarters, with growth averaging 33.0% over the last eight quarters.
- The best year-over-year quarter for Share-based Compensation over five years was Q2 2024 (growth of 122.4%); the worst was Q2 2022 (a decline of 2.9%).
- Per Business Quant data, MDGL's Share-based Compensation in the three quarters before Q2 2026 was $34.02 million (Q1 2026), $25.79 million (Q4 2025) and $26.25 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Madrigal Pharmaceuticals | 15.07 Bn | 11.32 Bn | - | 35.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.37 Mn |
| Mar 31, 2026 | 34.02 Mn |
| Dec 31, 2025 | 25.79 Mn |
| Sep 30, 2025 | 26.25 Mn |
| Jun 30, 2025 | 25.16 Mn |
| Mar 31, 2025 | 20.93 Mn |
| Dec 31, 2024 | 17.68 Mn |
| Sep 30, 2024 | 17.90 Mn |
| Jun 30, 2024 | 24.40 Mn |
| Mar 31, 2024 | 19.90 Mn |
| Dec 31, 2023 | 14.85 Mn |
| Sep 30, 2023 | 12.66 Mn |
| Jun 30, 2023 | 10.97 Mn |
| Mar 31, 2023 | 11.25 Mn |
| Dec 31, 2022 | 8.08 Mn |
| Sep 30, 2022 | 8.12 Mn |
| Jun 30, 2022 | 7.94 Mn |
| Mar 31, 2022 | 7.48 Mn |
| Dec 31, 2021 | 6.36 Mn |
| Sep 30, 2021 | 6.24 Mn |
API Access
Madrigal Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=MDGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "MDGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=MDGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();